Neuro-Oncology
Oligodendroglioma
Apr. 19, 2024
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
In this metabolic scheme illustrating the normal role of L-2-hydroxyglutarate dehydrogenase, L-malate dehydrogenase interconverts the citric acid intermediates oxaloacetate and L-malate using NADH/NAD+. L-malate dehydrogenase also converts alpha-ketoglutarate to L-2-OH-glutarate, but the reaction equilibrium is shifted towards L-2-OH-glutarate. Therefore, another enzyme, L-2-OH-glutarate dehydrogenase, is needed to convert L-2-OH-glutarate back to alpha-ketoglutarate and prevent toxic accumulation of L-2-OH-glutarate. (Adapted from: Rzem R, Veiga-da-Cunha M, Noel G, et al. A gene encoding a putative FAD-dependent L-2-hydroxyglutarate dehydrogenase is mutated in L-2-hydroxyglutaric aciduria. Proc Natl Acad Sci U S A 2004;101(48):16849-54.)